NasdaqCM - Nasdaq Real Time Price
USD
Cardiol Therapeutics Inc. (CRDL)
1.0400
-0.0700
(-6.31%)
At close: November 2 at 4:00:01 PM EST
Loading chart for CRDL
- Previous Close
1.1100 - Open
1.1100 - Bid 1.0300 x 500
- Ask 1.3300 x 200
- Day's Range
1.0310 - 1.1200 - 52 Week Range
0.8800 - 2.3400 - Volume
740,366 - Avg. Volume
1,382,707 - Market Cap (intraday)
126.373M - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2500 - Earnings Date (est.) Nov 12, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
8.56 - Zacks Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
CRDL
7.44%
S&P/TSX Composite index (^GSPTSE)
12.35%
1-Year Return
CRDL
7.96%
S&P/TSX Composite index (^GSPTSE)
18.31%
3-Year Return
CRDL
30.16%
S&P/TSX Composite index (^GSPTSE)
82.41%
5-Year Return
CRDL
69.50%
S&P/TSX Composite index (^GSPTSE)
69.11%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-90.92%
-
Return on Equity (ttm)
-190.18%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-34.08M
-
Diluted EPS (ttm)
-0.2500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
26.08M
-
Total Debt/Equity (mrq)
0.44%
-
Levered Free Cash Flow (ttm)
-15.48M
